Nanjing Sinolife United Co., Ltd. Class H (HK:3332)
:3332
Want to see HK:3332 full AI Analyst Report?
Top Page
Nanjing Sinolife United Co., Ltd. Class H
(3332)
Select Model
Select Model
Rating:58Neutral
Price Target:
HK$0.25
▼(-33.42% Downside)
Action:ReiteratedDate:05/01/26
The score is primarily supported by mid-range fundamentals (revenue growth and strong gross margins, but materially weaker net/operating profitability versus 2023 and uneven cash-flow history). The largest offset is technical weakness, with the stock in a pronounced downtrend and bearish momentum signals. Valuation is moderately supportive due to a low P/E, but lacks dividend data to further strengthen the case.
Positive Factors
High Gross Margin
A sustained ~73% gross margin indicates durable product-level economics and likely pricing power or favorable product mix in household & personal products. High gross margins create a structural buffer to absorb SG&A or input cost increases and support long-term reinvestment.
Negative Factors
Compressed Net Profitability
A sharp drop in net margin materially reduces long-term earnings power and ROE, implying either higher operating costs, heavier SG&A or other structural expense pressure. Sustained margin compression limits reinvestment capacity and resilience to cyclical downturns.
Read all positive and negative factors
Positive Factors
Negative Factors
High Gross Margin
A sustained ~73% gross margin indicates durable product-level economics and likely pricing power or favorable product mix in household & personal products. High gross margins create a structural buffer to absorb SG&A or input cost increases and support long-term reinvestment.
Read all positive factors
Nanjing Sinolife United Co., Ltd. Class H (3332) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$393.69M
Dividend YieldN/A
Average Volume (3M)6.00K
Price to Earnings (P/E)8.8
Beta (1Y)-0.22
Revenue Growth3.51%
EPS Growth-28.79%
CountryHK
Employees468
SectorConsumer Defensive
Sector Strength42
IndustryHousehold & Personal Products
Share Statistics
EPS (TTM)0.02
Shares Outstanding946,298,340
10 Day Avg. Volume16,600
30 Day Avg. Volume6,000
Financial Highlights & Ratios
PEG Ratio-0.44
Price to Book (P/B)0.77
Price to Sales (P/S)0.43
P/FCF Ratio4.97
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Nanjing Sinolife United Co., Ltd. Class H Business Overview & Revenue Model
Company Description
Nanjing Sinolife United Company Limited, an investment holding company, engages in the manufacture, processing, and sale of nutritional supplements in the People's Republic of China, Australia, New Zealand, Vietnam, and internationally. The compan...
Nanjing Sinolife United Co., Ltd. Class H Financial Statement Overview
Summary
Income Statement
68
Positive
Balance Sheet
70
Positive
Cash Flow
62
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 710.07M | 752.92M | 747.90M | 563.96M | 274.85M | 252.32M |
| Gross Profit | 512.97M | 550.75M | 538.27M | 379.66M | 160.00M | 138.80M |
| EBITDA | 24.97M | 35.97M | 48.19M | 75.08M | 4.88M | -13.49M |
| Net Income | 16.48M | 24.03M | 34.56M | 52.60M | -14.25M | -31.71M |
Balance Sheet | ||||||
| Total Assets | 549.33M | 603.72M | 505.56M | 505.42M | 436.99M | 390.11M |
| Cash, Cash Equivalents and Short-Term Investments | 140.84M | 240.36M | 104.53M | 122.79M | 78.19M | 76.23M |
| Total Debt | 55.37M | 107.24M | 33.90M | 35.16M | 35.75M | 8.87M |
| Total Liabilities | 126.22M | 186.58M | 111.46M | 127.35M | 113.19M | 59.87M |
| Stockholders Equity | 423.11M | 417.14M | 394.10M | 378.07M | 323.80M | 330.24M |
Cash Flow | ||||||
| Free Cash Flow | 40.62M | 64.92M | -6.65M | 44.76M | 4.05M | -9.68M |
| Operating Cash Flow | 42.72M | 68.63M | 957.00K | 47.11M | 7.92M | 421.00K |
| Investing Cash Flow | -897.00K | -725.00K | -6.00M | 449.00K | -3.47M | 1.52M |
| Financing Cash Flow | 15.47M | 11.84M | -4.53M | -4.50M | -4.08M | -4.45M |
Nanjing Sinolife United Co., Ltd. Class H Technical Analysis
Negative
0.38
Price Trends
0.40
Negative
0.39
Negative
0.41
Negative
Market Momentum
-0.01
Positive
18.10
Positive
13.54
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:3332, the sentiment is Negative. The current price of 0.38 is below the 20-day moving average (MA) of 0.39, below the 50-day MA of 0.40, and below the 200-day MA of 0.41, indicating a bearish trend. The MACD of -0.01 indicates Positive momentum. The RSI at 18.10 is Positive, neither overbought nor oversold. The STOCH value of 13.54 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:3332.
Nanjing Sinolife United Co., Ltd. Class H Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | HK$597.65M | 3.34 | 7.43% | 10.87% | -3.14% | -29.66% | |
64 Neutral | HK$431.33M | 8.37 | 3.43% | 15.24% | -4.01% | -36.23% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
58 Neutral | HK$393.69M | 8.80 | 5.83% | ― | 3.51% | -28.79% | |
55 Neutral | HK$383.60M | 6.87 | 10.20% | ― | 23.29% | 9.11% | |
50 Neutral | HK$551.12M | -20.98 | -10.69% | 1.72% | -3.49% | -1567.01% | |
48 Neutral | HK$951.00M | -702.74 | -12.38% | ― | 52.36% | ― |
* Consumer Defensive Sector Average
HK:3332
Nanjing Sinolife United Co., Ltd. Class H
0.22
-0.24
-52.22%
HK:3828
Ming Fai International Holdings
0.82
0.07
9.33%
HK:0157
Natural Beauty Bio-Technology
0.47
>-0.01
-1.05%
HK:2023
China Ludao Technology Co. Ltd.
0.80
-0.07
-8.05%
HK:2138
EC Healthcare
0.47
-0.20
-29.55%
HK:2177
UNQ Holdings Limited
2.60
0.72
38.30%
Nanjing Sinolife United Co., Ltd. Class H Corporate Events
Nanjing Sinolife Calls 2026 AGM, Seeks Fresh H-Share Issuance Mandate
Apr 23, 2026
Nanjing Sinolife United Company Limited has called its annual general meeting for 5 June 2026 in Nanjing, where shareholders will review the 2025 board and supervisory reports, audited consolidated financial statements, and the 2025 financial resu...
Nanjing Sinolife United Grows Revenue but Sees 2025 Profit Squeezed
Mar 27, 2026
Nanjing Sinolife United reported modest top-line growth for 2025, with revenue rising 3.3% to RMB772.9 million and gross profit up 5.2% to RMB566.2 million, reflecting slightly improved margins. However, the company’s net profit declined to ...
Nanjing Sinolife United Sets March 2026 Board Meeting to Approve 2025 Results
Mar 17, 2026
Nanjing Sinolife United has scheduled a board meeting for 27 March 2026 to review and approve the group’s audited final results for the financial year ended 31 December 2025. The board will also consider recommending a final dividend, if any...
Nanjing Sinolife Flags Profit Drop on Higher E-Commerce Promotion Spend
Mar 9, 2026
Nanjing Sinolife United Company Limited has warned investors that its net profit for 2025 is expected to fall to about RMB18 million to RMB26 million, down from roughly RMB34.6 million a year earlier. The decline is mainly attributed to higher bra...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.